ESSA Pharma is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding ESSA’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ESSA or its management. ESSA does not, by its reference above, imply its endorsement of or concurrence with such information, conclusions or recommendations.
Bloom Burton & Co.
David Martin, PhD & MBA
Managing Director & Head of Equity Research
Oppenheimer & Co.
Mark Breidenbach, PhD
Managing Director & Senior Healthcare Analyst
Maury Raycroft, PhD
Biotechnology Equity Research Analyst
Piper | Sandler
Joseph Catanzaro, Ph.D.
Senior Biotech Analyst